Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
Get Insiders for : 
Alnylam Pharmaceuticals Inc (ALNY)  
$149.30 2.76 (1.82%) as of 4:30 Thu 6/6


Download
   
Exchange: Nasdaq National Market
Security Type: Common
Shares Out: 123,030,000
Market Cap: 18.37(B)
Last Volume: 534,229 Avg Vol: 722,222
52 Week Range: $143.31 - $211.65
Level I Sector: Health Care
Level II Sector: Drugs
Level III Sector: Biotechnology

Member Indexes:
    NASDAQ BIOTECHNOLOGY     NASDAQ COMPOSITE
    NASDAQ NNM COMPOSITE

Rankings:
     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  824
Guru Rank Value     : 0.5
Guru Occurances    : 1

 

            6 Months   1 Year   2 Year  
 
Company Profile   Alnylam Pharmaceuticals is a commercial-stage biopharmaceutical company developing therapeutics based on RNA interference. Co. has four RNAi-based medicines, ONPATTRO® (patisiran), GIVLAARI® (givosiran), OXLUMO™ (lumasiran) and Leqvio® (inclisiran). ONPATTRO is approved for the treatment of the polyneuropathy of hereditary transthyretin-mediated amyloidosis in adults. GIVLAARI is approved for the treatment of adults with acute hepatic porphyria. Co. has approval for OXLUMO for the treatment of hyperoxaluria type 1 (PH1) in all age groups. Leqvio (inclisiran) is being developed for the treatment of adults with hypercholesterolemia or mixed dyslipidemia.

 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 0 0 0
Total Buy Value $0 $0 $0 $0
Total People Bought 0 0 0 0
Total Buy Transactions 0 0 0 0
Total Shares Sold 21,700 98,555 124,204 268,793
Total Sell Value $3,224,546 $16,182,261 $20,937,886 $52,053,725
Total People Sold 1 8 9 10
Total Sell Transactions 1 13 19 36
End Date 2024-03-07 2023-12-05 2023-06-06 2022-06-06

   
Records found: 748
  Page 23 of 30  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

  
3m +/-  
Form
   Sharp Philip A Director   –       •      –    2013-01-22 4 B $20.13 $99,986 D/D 4,967 14,269 2.39     -
   Maraganore John CEO   •       •      –    2012-12-19 4 OE $0.48 $8,843 D/D 18,617 77,120     -
   Vaishnaw Akshay EVP, Chief Medical Officer   •       –      –    2012-12-12 4 AS $19.00 $190,000 D/D (10,000) 12,588     -
   Vaishnaw Akshay EVP, Chief Medical Officer   •       –      –    2012-12-12 4 OE $9.14 $92,400 D/D 10,000 22,588     -
   Vaishnaw Akshay EVP, Chief Medical Officer   •       –      –    2012-12-10 4 AS $17.00 $81,209 D/D (4,777) 12,588     -
   Vaishnaw Akshay EVP, Chief Medical Officer   •       –      –    2012-12-10 4 OE $7.10 $33,917 D/D 4,777 17,365     -
   Vaishnaw Akshay EVP, Chief Medical Officer   •       –      –    2012-12-04 4 AS $17.04 $40,896 D/D (2,400) 12,588     -
   Vaishnaw Akshay EVP, Chief Medical Officer   •       –      –    2012-12-04 4 OE $7.10 $17,040 D/D 2,400 14,988     -
   Vaishnaw Akshay EVP, Chief Medical Officer   •       –      –    2012-11-30 4 AS $17.03 $48,072 D/D (2,823) 12,588     -
   Vaishnaw Akshay EVP, Chief Medical Officer   •       –      –    2012-11-30 4 OE $7.10 $20,043 D/D 2,823 15,411     -
   Mason Michael VP, Finance and Treasurer   •       –      –    2012-11-30 4 AS $16.93 $63,472 D/D (3,750) 7,847     -
   Mason Michael VP, Finance and Treasurer   •       –      –    2012-11-30 4 OE $7.10 $26,625 D/D 3,750 11,597     -
   Novartis Pharma Ag 10% Owner   –       –       •   2012-09-20 4 S $19.42 $30,137,820 I/I (1,551,896) 4,051,002     -
   Vaishnaw Akshay EVP, Chief Medical Officer   •       –      –    2012-09-12 4 AS $19.00 $93,404 D/D (4,916) 12,588     -
   Vaishnaw Akshay EVP, Chief Medical Officer   •       –      –    2012-09-12 4 OE $9.30 $45,719 D/D 4,916 17,504     -
   Vaishnaw Akshay EVP, Chief Medical Officer   •       –      –    2012-09-10 4 AS $19.00 $25,346 D/D (1,334) 12,588     -
   Vaishnaw Akshay EVP, Chief Medical Officer   •       –      –    2012-09-10 4 OE $9.30 $12,406 D/D 1,334 13,922     -
   Mason Michael VP, Finance and Treasurer   •       –      –    2012-07-27 4 AS $20.00 $125,000 D/D (6,250) 7,847     -
   Mason Michael VP, Finance and Treasurer   •       –      –    2012-07-27 4 OE $10.98 $68,625 D/D 6,250 14,097     -
   Vaishnaw Akshay SVP, Chief Medical Officer   •       –      –    2012-07-16 4 AS $19.00 $688,750 D/D (36,250) 12,588     -
   Vaishnaw Akshay SVP, Chief Medical Officer   •       –      –    2012-07-16 4 OE $9.14 $335,325 D/D 36,250 23,838     -
   Mason Michael VP, Finance & Treasurer   •       –      –    2012-07-16 4 AS $18.00 $284,043 D/D (15,295) 7,847     -
   Mason Michael VP, Finance & Treasurer   •       –      –    2012-07-16 4 OE $9.14 $174,554 D/D 15,295 14,409     -
   Ausiello Dennis A Director   –       •      –    2012-04-20 3 IO $0.00 $0 I/I 0 3,500     -
   Ausiello Dennis A Director   –       •      –    2012-04-20 3 IO $0.00 $0 D/D 0 13,165     -
  748 Records found
  Previous  20  21  22  23  24  25  26  27  28  29  Next   
  Page 23 of 30
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us